Faisal Alotaibi

Faisal Alotaibi

Auto-generated profile, based on publicly available information

Faisal Alotaibi

Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2023 in Journal of Clinical Periodontology
Verified
Journal Article
Open access
FAFaisal F. Alotaibi
Faisal F. Alotaibi
IRIsabella Rocchietta
Isabella Rocchietta
JBJacopo Buti
Jacopo Buti
FDFrancesco D'Aiuto
Francesco D'Aiuto
Aim: To systematically appraise the available evidence on vertical ridge augmentation (VRA) techniques and estimate a treatment‐based ranking on the incidence of complications as well as their clinical effectiveness.Materials and Methods: Searches were conducted in six databases to identify randomized clinical trials comparing VRA techniques up to November 2022. The incidence of complications (primary) and of early, major, surgical and intra‐operative complications, vertical bone gain (VBG), marginal bone loss, need for additional grafting, implant success/survival, and patient‐reported outcome measures (secondary) were chosen as outcomes. Direct and indirect effects and treatment ranking were estimated using Bayesian pair‐wise and network meta‐analysis (NMA) models.Results: Thirty‐two trials (761 participants and 943 defects) were included. Five NMA models involving nine treatment groups were created: onlay, inlay, dense‐polytetrafluoroethylene, expanded‐polytetrafluoroethylene, titanium, resorbable membranes, distraction osteogenesis, tissue expansion and short implants. Compared with short implants, statistically significant higher odds ratios of healing complications were confirmed for all groups except those with resorbable membranes (odds ratio 5.4, 95% credible interval 0.92–29.14). The latter group, however, ranked last in clinical VBG.Conclusions: VRA techniques achieving greater VBG are also associated with higher incidence of healing complications. Guided bone regeneration techniques using non‐resorbable membranes yield the most favourable results in relation to VBG and complications.

9 August 2025 in Regenerative Medicine
Verified
Journal Article
Open access
FAFaisal F. Alotaibi
Faisal F. Alotaibi
ZAZainab M. AlFaltawi
Zainab M. AlFaltawi
SOSharon R. Oyhanart
Sharon R. Oyhanart
JKJonathan Knowles
Jonathan Knowles
FDFrancesco D'Aiuto
Francesco D'Aiuto
DCDavid YS Chau
David YS Chau
The eggshell membrane (ESM) is a natural resource with a distinct design and composition, offering structural features consistent with barrier membranes used in guided bone regeneration (GBR), making it a promising candidate for this application. This study aims to assess the feasibility of chicken and duck ESMs as GBR alternatives by comparing them with resorbable porcine-derived collagen (Porcine CM, Bio-Gide®) and non-resorbable dense polytetrafluoroethylene (d-PTFE, CytoplastTM). ESMs were extracted using a standardized protocol. Membranes were then analyzed using scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), dynamic mechanical analysis (DMA), contact angle measurements (CAM), and cell culture-based assays. FTIR revealed similar collagen spectra among membranes. SEM showed structural similarities between ESMs and Bio-Gide. DSC indicated integrity maintenance at 37°C and varied storage conditions. CAM testing demonstrated collagen-based membranes' higher hydrophilicity compared to d-PTFE. DMA analysis showed duck ESM's superior tensile strength and Young's modulus compared to chicken ESM and porcine CM. Biological evaluation revealed high compatibility with human gingival fibroblasts for all materials. Findings illustrate a novel sustainable biomaterial that could be utilized for GBR and other periodontal therapies, particularly in its capacity to function as a physical barrier consistent with the traditional role of GBR membranes.

21 March 2025 in Clinical Oral Implants Research
Verified
Journal Article
Open access
FAFaisal Faihan Alotaibi
Faisal Faihan Alotaibi
JBJacopo Buti
Jacopo Buti
IRIsabella Rocchietta
Isabella Rocchietta
NNNor Shafina Binti Mohamed Nazari
Nor Shafina Binti Mohamed Nazari
RARawan Almujaydil
Rawan Almujaydil
FDFrancesco D'Aiuto
Francesco D'Aiuto
Objectives: To systematically appraise the evidence on premature ridge resorption following various vertical ridge augmentation (VRA) techniques in healthy adult patients undergoing staged VRA procedures. The study aimed to identify VRA techniques resulting in the least premature bone resorption and to rank them using Bayesian Network Meta‐Analysis (NMA). Material and Methods: Searches were conducted in six databases to identify randomised clinical trials (RCT) comparing staged VRA techniques with a minimum of 3 months follow‐up. Relative premature bone resorption (PBR%) overall (primary) and in sites with uneventful versus complicated healing and need for additional bone grafting (NAG) (secondary) were chosen as outcomes. The risk of bias and certainty in evidence were assessed using Cochrane RoB 2.0 and GRADE tools. Bayesian models estimated treatment effects and rankings. Results: Ten RCTs, involving 220 participants and 236 defects, were included. Nine RCTs reported mean PBR%, with a range from 6% to 44%, averaging 26%. Seven treatment groups were evaluated: onlay, onlay + barrier, inlay, guided bone regeneration, distraction osteogenesis (DO), tissue expansion + tunnelling (TET), and cortical tenting. Eight RCTs, involving 160 participants and 176 defects, contributed to the NMA. Compared to onlay, all groups had lower mean PBR%. Inlay had the highest probability of being ranked first (Pr = 0.55), followed by DO (Pr = 0.27) and TET (Pr = 0.15). Healing complications significantly increased PBR% (MD 10%, 95% CrI 4.4–15.7). Conclusion: VRA techniques preserving the periosteum (inlay, DO, and TET) exhibit less PBR compared with other techniques. When techniques involve full flap elevation, clinicians should anticipate volume loss at re‐entry and consider greater grafting volumes to offset PBR. Protocol Registration: PROSPERO ID: CRD42023394396; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=394396

19 November 2019
Verified
Conference Paper
Open access
PDF file
RARaghad Alonazi
Raghad Alonazi
RARahaf Alonazi
Rahaf Alonazi
AAAmna Al-Ahmed
Amna Al-Ahmed
HAHajar Arnous
Hajar Arnous
FAFaisal Alotaibi
Faisal Alotaibi
HAHetaf Alammar
Hetaf Alammar
Aim The aim of our systematic review and meta-analysis was to synthesise the high-quality evidence on the efficacy and safety of pharmacological interventions to manage sleep problems in children and adolescents with autism spectrum disorder (ASD). Methods The studies we included here were (RCTs) looking at the efficacy and safety of pharmacological intervention for sleep problems in children and adolescents with ASD. The studies had to include objective sleep measures and/or subjective sleep measures. They all dealt with pharmacological interventions, with medications including melatonin and antipsychotics, and they all compared these drugs with placebos. We used four databases: ERIC, ProQuest, PubMed and Ovid Medline. We assessed the papers in accordance with the Cochrane risk of bias tool. Results We found six studies that used RCT designs. Five of them used melatonin, and one study used an antipsychotic. In studies using melatonin, a meta-analysis revealed that there was a large effect size of using melatonin in reducing sleep latency in children and adolescents with ASD. The overall effect size was -0.87 (95% confidence interval [CI]) -1.11, -0.63, Z=7.11 (P<0.00001). In terms of antipsychotics, our review revealed that the antipsychotic resperidon was safe and effective in managing sleep problems in children and adolescents with ASD. Both melatonin and resperidon improved sleep latency and reduced night-time awakenings. However, mild side effects were reported in a small number of participants (figure 1). Meta-analysis of the efficacy of using melatonin in improving sleep latency in children and adolescents with ASD Discussion Although the quality of the evidence in these studies was moderate according to the GRADE approach, both melatonin and resperidon seem to be safe and effective in improving sleep in children and adolescents with ASD. Some side effects have been observed in a small number of children. Observing and recording side effects is crucial to control medication doses.

17 August 2026 in Micro
Verified
Journal Article
Open access
PDF file
RSRAJASHEKHARA BHARI SHARANESHA
RAJASHEKHARA BHARI SHARANESHA
DVDEEPTI VIRUPAKSHAPPA
DEEPTI VIRUPAKSHAPPA
MAMaram Abdulaziz Alagla
Maram Abdulaziz Alagla
ZAZeyad Alkwaifali
Zeyad Alkwaifali
FAFaisal Alotaibi
Faisal Alotaibi
Background/Objectives: Nanotechnology has become a transformative area in modern dentistry, providing new opportunities for better diagnosis, targeted drug delivery, improved restorative materials, antimicrobial treatments, and tissue regeneration. This scoping review outlines the scope, key developments, and future directions of nanotechnology use across all dental specialties, highlights emerging innovations, and identifies major translational challenges and research priorities. Methods: This review followed the Joanna Briggs Institute (JBI) methodology for scoping reviews and adhered to the PRISMA-ScR guidelines. These guidelines, originally by Arksey and O’Malley (2005) and later updated by Levac et al. (2010) and Peters et al. (2020, 2021), guided the process. The Population, Concept, and Context (PCC) framework guided the eligibility criteria. Included studies were primary research or reviews reporting nanotechnology applications in any dental specialty, published in English, with no date restriction. Excluded were non-peer-reviewed sources, conference abstracts without full text, studies unrelated to dental applications, and non-English publications. A comprehensive literature search was conducted across PubMed/MEDLINE, Scopus, and Web of Science. After screening titles and abstracts and reviewing full texts, 133 studies were included. Results: The included studies covered a wide range of fields such as restorative dentistry, implantology, periodontology, endodontics, drug delivery, tissue regeneration, oral diagnostics, antimicrobial applications, prosthodontics, orthodontics, and emerging technologies like nanorobotics and graphene-based systems. The most commonly reported nanomaterials were silver nanoparticles (AgNPs), calcium phosphate nanoparticles (CaP NPs), and polymeric nanoparticles such as PLGA and chitosan. Additionally, there was a notable increase in publications starting from 2019. Conclusions: Nanotechnology offers transformative possibilities in every area of dentistry. Nonetheless, challenges such as nanotoxicology safety, regulatory alignment, and effective clinical application need resolution. Essential steps include standardized characterization, gathering long-term safety data, and establishing international regulatory standards to ensure safe adoption of nano dentistry.

4 August 2026 in Data
Verified
Journal Article
Open access
PDF file
DVDEEPTI VIRUPAKSHAPPA
DEEPTI VIRUPAKSHAPPA
RSRAJASHEKHARA BHARI SHARANESHA
RAJASHEKHARA BHARI SHARANESHA
AAAlWaleed Abushanan
AlWaleed Abushanan
SASara Ayid Alghamdi
Sara Ayid Alghamdi
MAMaram Abdulaziz Alagla
Maram Abdulaziz Alagla
FAFaisal Alotaibi
Faisal Alotaibi
Background: Dental insurance claims data are vital for research in oral health, epidemiology, and policy. However, issues like data quality, coding standards, validity, interoperability, and analytical approaches hinder their use. This review outlines these challenges. Methods: Following PRISMA-ScR and Arksey-O’Malley, we searched Web of Science, Scopus, and PubMed through April 2026 for peer-reviewed studies on dental insurance data issues. Two reviewers screened and extracted data, identifying key challenges and implications. Results: Out of 563 records, 389 remained after deduplication; 45 studies met criteria. Data sources included Medicaid, Medicare, insurers, and national systems from various countries. Six main challenges emerged: (1) coding errors and lack of standardization; (2) data validity and quality concerns; (3) interoperability and linkage barriers; (4) fraud detection issues; (5) analytical limitations; (6) policy insights on disparities. Validation showed variable accuracy, with diagnosis codes more reliable than procedure codes. Conclusions: Challenges limit data use in research and policy. Standardized coding, validation, interoperability, transparency, and causal inference are essential for leveraging these data to improve oral health research and policies.